PJ
Pramod Jaykumar Wategave
About Pramod Jaykumar Wategave
Data last updated:
Pramod Jaykumar Wategave is a Director at Skylark Precitech Private Limited (since 2021) and Director at Skyline Biotech Private Limited (since 2021). The companies operate in Machinery and Equipment and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.66 Cr; the largest is Skylark Precitech Private Limited at ₹1.66 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2021 | 2005 | ₹1.66 Cr (FY 2024) | Active | |
| Director | 12 Feb 2021 | 2021 | ₹71,875 (FY 2025) | Active |
Board colleagues of Pramod Jaykumar Wategave
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhalchandra Virendra Patil | 00108726 | Skylark Precitech Private Limited , Skyline Biotech Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pramod Jaykumar Wategave
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pramod Jaykumar Wategave
Pramod Jaykumar Wategave currently holds 2 directorships: Skylark Precitech Private Limited (Director, since 01 Jul 2021, revenue ₹1.66 Cr (FY 2024)); Skyline Biotech Private Limited (Director, since 12 Feb 2021, revenue ₹71,875 (FY 2025)).
Pramod Jaykumar Wategave was first appointed on 12 Feb 2021 as Director at Skyline Biotech Private Limited.
The 2 current companies of Pramod Jaykumar Wategave that report revenue have a combined latest revenue of ₹1.66 Cr: Skylark Precitech Private Limited ₹1.66 Cr (FY 2024); Skyline Biotech Private Limited ₹71,875 (FY 2025).
The current boards of Pramod Jaykumar Wategave's companies include Bhalchandra Virendra Patil (Skylark Precitech Private Limited).